Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Peres, Fernanda F; Lima, Alvaro C; Hallak, Jaime E C; Crippa, José A; Silva, Regina H; Abílio, Vanessa C

Peres, Fernanda F; Lima, Alvaro C; Hallak, Jaime E C; Crippa, José A; Silva, Regina H; Abílio, Vanessa C.

Afiliación

Peres FF; Laboratory of Behavioral Neurosciences, Department of Pharmacology, Federal University of São Paulo, São Paulo, Brazil.
Lima AC; National Institute for Translational Medicine (INCT-TM, CNPq, FAPESP, CAPES), Ribeirão Preto, Brazil.
Hallak JEC; Laboratory of Behavioral Neurosciences, Department of Pharmacology, Federal University of São Paulo, São Paulo, Brazil.
Crippa JA; National Institute for Translational Medicine (INCT-TM, CNPq, FAPESP, CAPES), Ribeirão Preto, Brazil.
Silva RH; Department of Neuroscience and Behavior, University of São Paulo, Ribeirão Preto, Brazil.
Abílio VC; National Institute for Translational Medicine (INCT-TM, CNPq, FAPESP, CAPES), Ribeirão Preto, Brazil.

Front Pharmacol ; 9: 482, 2018.

Article en En | MEDLINE | ID: mdl-29867488

Palabras clave

Huntington's disease; Parkinson's disease; cannabidiol; cannabinoids; dystonic disorders; movement disorders

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google